Keyphrases
Rosiglitazone
100%
Uraemic Rats
100%
L-arginine Transport
100%
Chronic Kidney Disease
85%
Endothelial Nitric Oxide Synthase (eNOS)
21%
Arginine Uptake
21%
Beneficial Effects
14%
Uremia
14%
Protein Nitration
14%
Novel Mechanism
7%
Attenuation
7%
Protein Content
7%
Western Blot Analysis
7%
Endothelium
7%
Immunohistochemical Analysis
7%
Cyclic GMP
7%
Failure Effects
7%
Nitric Oxide Synthase Activity
7%
Aortic Rings
7%
Phorbol 12-myristate 13-acetate
7%
Choline
7%
Endothelial Function
7%
Membrane Fraction
7%
Peroxisome Proliferator-activated Receptor Agonists
7%
Immunobloting
7%
5/6 Nephrectomy
7%
Animal. Rats
7%
Arginine Transporter
7%
PKC Phosphorylation
7%
Medicine and Dentistry
Arginine
100%
Rosiglitazone
100%
Chronic Kidney Disease
85%
Endothelial Nitric Oxide Synthase
21%
Uremia
14%
Immunohistochemistry
7%
Atherosclerosis
7%
Ex Vivo
7%
Western Blot
7%
Endothelial Function
7%
Carbachol
7%
Peroxisome Proliferator Activated Receptor Agonist
7%
Nephrectomy
7%
Phorbol 13 Acetate 12 Myristate
7%
Cyclic GMP
7%
Pharmacology, Toxicology and Pharmaceutical Science
Rosiglitazone
100%
Arginine
100%
Chronic Kidney Failure
85%
Endothelial Nitric Oxide Synthase
21%
Uremia
14%
Western Blot
7%
Atherosclerosis
7%
Carbachol
7%
12-O-Tetradecanoylphorbol-13-Acetate
7%
PPAR Agonist
7%
Cyclic GMP
7%